Quick Takeaways
- DBVT - DBV Technologies S.A. has 17 insiders with reported activity on this page.
- Net insider value flow over the last year: -$15,511,706.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 17 Insiders of DBV Technologies S.A.
- Symbol
- DBVT on Nasdaq, DBVTF on OTC
- Location
- Chatillon, France
What Changed
- Buy value: ; sell value: $15,511,705.
- Net share flow: -3,378,608.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$15,511,706.
Buys
$0
Shares: 0
Insiders: 0
Sells
$15,511,706
Shares: 3,378,608
Insiders: 2
Net
-$15,511,706
Shares: -3,378,608
Insiders: -2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 534 | $0 | $2,595 | -$2,595 |
| 3-6 | 0 | 3,377,213 | $0 | $15,507,350 | -$15,507,350 |
| 6-9 | 0 | 464 | $0 | $1,030 | -$1,030 |
| 9-12 | 0 | 397 | $0 | $730 | -$730 |
DBV Technologies S.A. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bpifrance Epic | Member of 10% owner group | $33,531,799 | -$15,484,143 | -32% | Mixed | 17 Dec 2025 |
| Bpifrance SA | 10%+ Owner | $9,263,806 | Mixed | 27 Mar 2025 | ||
| Bpifrance Investissement S.A.S. | Member of 10% owner group | $1,542,113 | Mixed | 27 Mar 2025 | ||
| Virginie Boucinha | Chief Financial Officer | $986,300 | Mixed | 21 Nov 2025 | ||
| Kevin Michael Trapp | Chief Commercial Officer | $774,950 | Mixed | 21 Nov 2025 | ||
| Pharis Mohideen | Chief Medical Officer | $704,675 | -$27,563 | -3.8% | Filing P/S | 29 Jan 2026 |
| Sebastien Robitaille | Chief Financial Officer | $63,510 | Mixed | 21 Nov 2022 | ||
| Daniel B. Soland | Director | $34,800 | Mixed | 01 Aug 2023 | ||
| Timothy E. Morris | Director | $20,880 | Mixed | 25 Aug 2023 | ||
| Adora Ndu | Director | $1,624 | Filing P/S | 06 Feb 2024 | ||
| Philina Lee | Director | Mixed | 30 Oct 2025 | |||
| Daniel Tasse | CHIEF EXECUTIVE OFFICER, Director | Mixed | 21 Nov 2025 | |||
| BAKER BROS. ADVISORS LP | Director | Mixed | 12 Jan 2026 | |||
| Madduri Ravin Rao | Director | Mixed | 10 Jun 2021 | |||
| Viviane Monges | Director | Mixed | 10 Jun 2021 | |||
| Michel de Rosen | Director | Mixed | 10 Jun 2021 | |||
| Daniele Guyot-Caparros | Director | Mixed | 03 Oct 2022 |
Top shareholders of DBV Technologies S.A. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
|
Director · Company |
10%
|
25,586,190
|
$490,489,821 | +$40,190,632 | 12 Jan 2026 | |
| MPM BioImpact LLC |
13D/G
13F
|
Company |
9.9%
|
24,579,307
|
$440,706,975 | $0 | 31 Dec 2025 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
5.7%
|
15,685,950
|
$281,249,084 | -$83,778,284 | 12 Jan 2026 | |
| Invus Global Management, LLC |
13D/G
|
Raymond Debbane |
6.2%
|
14,350,960
|
$257,312,713 | +$50,428,125 | 31 Dec 2025 | |
| Bpifrance Participations SA |
13D/G
|
Caisse des Depots |
4.7%
|
10,898,595
|
$208,927,156 | -$1,663,524 | 05 Jan 2026 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
10%
|
14,614,449
|
$156,228,460 | $0 | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
|
— |
9.9%
|
15,176,015
|
$129,451,408 | $0 | 07 Apr 2025 | |
| Artisan Partners Limited Partnership |
13D/G
13F
|
Artisan Partners Asset Management Inc. · Company |
7%
|
3,309,055
|
$63,484,551 | $0 | 31 Dec 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
0.99%
|
2,461,626
|
$47,189,370 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.75%
|
1,857,362
|
$35,605,630 | — | 31 Dec 2025 | |
| Bpifrance Epic |
3/4/5
|
Member of 10% owner group |
3%
|
7,529,502
|
$33,531,799 | -$15,484,143 | 17 Dec 2025 | |
| BRAIDWELL LP |
13D/G
|
— |
2.5%
|
2,393,815
|
$20,419,242 | $0 | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
640,885
|
$12,285,765 | — | 31 Dec 2025 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
0.26%
|
639,769
|
$12,264,372 | — | 31 Dec 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.23%
|
574,200
|
$11,007,414 | — | 31 Dec 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.22%
|
549,840
|
$10,540,433 | — | 31 Dec 2025 | |
| Bpifrance SA |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
10,898,595
|
$9,263,806 | — | 27 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.18%
|
454,343
|
$8,709,753 | — | 31 Dec 2025 | |
| Patient Square Capital LP |
13F
|
Company |
0.14%
|
359,050
|
$6,882,989 | — | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.12%
|
300,000
|
$5,751,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
244,862
|
$4,694,005 | — | 31 Dec 2025 | |
| Squadron Capital Management LLC |
13F
|
Company |
0.1%
|
240,000
|
$4,600,800 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.09%
|
235,023
|
$4,505,391 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.09%
|
223,186
|
$4,278,476 | — | 31 Dec 2025 | |
| Atika Capital Management LLC |
13F
|
Company |
0.08%
|
206,881
|
$3,965,909 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
163,401
|
$3,132,397 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
13D/G
|
Company · Kenneth Griffin |
3.5%
from 13D/G
|
145,129
|
$2,782,123 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
122,495
|
$2,348,229 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.21%
|
525,000
|
$2,084,239 | — | 31 Dec 2025 | |
| Bpifrance Investissement S.A.S. |
3/4/5
|
Member of 10% owner group |
0.09%
|
226,133
|
$1,542,113 | — | 27 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.03%
|
66,341
|
$1,271,757 | — | 31 Dec 2025 | |
| Polymer Capital Management (HK) LTD |
13F
|
Company |
0.03%
|
64,500
|
$1,236,465 | — | 31 Dec 2025 | |
| Virginie Boucinha |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
262,000
mixed-class rows
|
$986,300 | — | 21 Nov 2025 | |
| Optiver Holding B.V. |
13F
|
Company |
0.02%
|
47,728
|
$914,946 | — | 31 Dec 2025 | |
| Kevin Michael Trapp |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
371,250
mixed-class rows
|
$774,950 | — | 21 Nov 2025 | |
| NAN FUNG TRINITY (HK) Ltd |
13F
|
Company |
0.01%
|
37,095
|
$711,111 | — | 31 Dec 2025 | |
| Pharis Mohideen |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
397,995
mixed-class rows
|
$704,675 | -$27,563 | 29 Jan 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
33,947
|
$650,764 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
28,379
|
$544,025 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
27,211
|
$521,635 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.01%
|
25,000
|
$479,250 | — | 31 Dec 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.01%
|
24,984
|
$478,943 | — | 31 Dec 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
22,392
|
$429,255 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
20,961
|
$401,821 | — | 31 Dec 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.01%
|
15,877
|
$304,362 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
13,736
|
$263,319 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.01%
|
13,115
|
$251,414 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
6,433
|
$123,315 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0%
|
6,019
|
$115,384 | — | 31 Dec 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
3,892
|
$74,610 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for DBV Technologies S.A.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -0.37% | $2,595 | $4.86 | -534 | 144,995 | 29 Jan 2026 | Direct |
| Baker Bros. Advisors Lp | DBVT | Second Pre-Funded Warrant | Options Exercise | 27,304,896 | 25,005,240 | 12 Jan 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | DBVT | BS Warrant | Options Exercise | -100% | -27,304,896 | 0 | 12 Jan 2026 | See Footnotes | ||
| Bpifrance Epic | DBVT | Ordinary Shares | Sale | -15% | $5,413,912 | $4.19 | -1,292,103 | 7,303,369 | 18 Dec 2025 | By Bpifrance Participations S.A. |
| Bpifrance Epic | DBVT | Ordinary Shares | Sale | -19.5% | $10,070,232 | $4.85 | -2,076,990 | 8,595,472 | 17 Dec 2025 | By Bpifrance Participations S.A. |
| Pharis Mohideen | DBVT | Ordinary Shares | Award | 43.3% | 44,000 | 145,529 | 21 Nov 2025 | Direct | ||
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -1.57% | $4,498 | $2.77 | -1,624 | 101,529 | 21 Nov 2025 | Direct |
| Pharis Mohideen | DBVT | Employee Stock Option (right to buy) | Award | 253,000 | 253,000 | 21 Nov 2025 | Direct | |||
| Virginie Boucinha | DBVT | Ordinary Shares | Award | 84.2% | 32,000 | 70,000 | 21 Nov 2025 | Direct | ||
| Virginie Boucinha | DBVT | Employee Stock Option (right to buy) | Award | 192,000 | 192,000 | 21 Nov 2025 | Direct | |||
| Kevin Michael Trapp | DBVT | Ordinary Shares | Award | 55,000 | 55,000 | 21 Nov 2025 | Direct | |||
| Kevin Michael Trapp | DBVT | Employee Stock Option (right to buy) | Award | 316,250 | 316,250 | 21 Nov 2025 | Direct | |||
| Daniel Tasse | DBVT | Employee Stock Option (right to buy) | Award | 964,000 | 964,000 | 21 Nov 2025 | Direct | |||
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -5.92% | $18,708 | $2.88 | -6,496 | 103,153 | 20 Nov 2025 | Direct |
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -0.42% | $1,030 | $2.22 | -464 | 109,649 | 29 Jul 2025 | Direct |
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -0.36% | $730 | $1.84 | -397 | 110,113 | 22 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.